Bioindustry ethics / David L. Finegold [and others].

Contributor(s):

Finegold, David

Material type: Text

text

Media type:

computer

Carrier type:

online resource

ISBN:

9780123693709
0123693705
9780080492513
0080492517
1281005339
9781281005335

Subject(s): Genre/Form:

Additional physical formats: Print version:: Bioindustry ethics.DDC classification:

174/.96606 22

LOC classification:

HD9999.B442 B542 2005eb

NLM classification:

2006 G-784
WB 60

Online resources:

Click here to access online

Contents:

Preface -- Introduction -- Leadership -- Starting Right -- Ethics in an Emerging Field -- Getting Advice -- Self-Assessment -- Endnotes.

Summary: This book is the first systematic, detailed treatment of the approaches to ethical issues taken by biotech and pharmaceutical companies. The application of genetic/genomic technologies raises a whole spectrum of ethical questions affecting global health that must be addressed. Topics covered in this comprehensive survey include considerations for bioprospecting in transgenics, genomics, drug discovery, and nutrigenomics, as well as how to improve stakeholder relations, design ethical clinical trials, avoid conflicts of interest, and establish ethics advisory boards. The expert authors represent multiple disciplines including law, medicine, bioinformatics, pharmaceutics, business, and ethics.

Item type:

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Home library	Collection	Call number	Materials specified	Status	Date due	Barcode
Electronic-Books	OPJGU Sonepat- Campus	E-Books EBSCO			Available

This book is the first systematic, detailed treatment of the approaches to ethical issues taken by biotech and pharmaceutical companies. The application of genetic/genomic technologies raises a whole spectrum of ethical questions affecting global health that must be addressed. Topics covered in this comprehensive survey include considerations for bioprospecting in transgenics, genomics, drug discovery, and nutrigenomics, as well as how to improve stakeholder relations, design ethical clinical trials, avoid conflicts of interest, and establish ethics advisory boards. The expert authors represent multiple disciplines including law, medicine, bioinformatics, pharmaceutics, business, and ethics.

Preface -- Introduction -- Leadership -- Starting Right -- Ethics in an Emerging Field -- Getting Advice -- Self-Assessment -- Endnotes.